Stampa

W06 Ricerca farmaco

CARFILZOMIB - LENALIDOMIDE - DEXAMETHASONE (KRd) versus LENALIDOMIDE - DEXAMETHASONE (Rd) IN NEWLY DIAGNOSED MYELOMA PATIENTS NOT ELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANTATION: A RANDOMIZED PHASE III TRIAL
2018-002068-15
FO.NE.SA. Onlus
EMN20
17-06-2019
25-06-2019
0,00
150,00
150,00

Pincipal investigators

Ematologia di Ravenna
Claudia Cellini